Table 3.
Clinician recommended aspirin | |||
---|---|---|---|
Independent variable | No | Yes | p value |
% (n = 713) |
% (n = 409) |
||
Age at screening | 0.0026 | ||
45–54 | 74 | 26 | |
55–64 | 67 | 33 | |
65–79 | 48 | 52 | |
Sex | NS | ||
Male | 66 | 34 | |
Female | 58 | 42 | |
Race | NS | ||
Non-White | 67 | 33 | |
White | 64 | 36 | |
Citizenship status | 0.0032 | ||
No | 81 | 19 | |
Yes | 64 | 36 | |
Language of interview | 0.0839 | ||
English | 65 | 35 | |
Spanish | 73 | 27 | |
Education | NS | ||
< High school education | 62 | 38 | |
High school degree | 64 | 36 | |
> High school education | 67 | 33 | |
Health Insurance Status | 0.0001 | ||
No | 84 | 16 | |
Yes | 61 | 39 | |
General health condition | NS | ||
Excellent | 67 | 33 | |
Very good | 69 | 31 | |
Good | 65 | 35 | |
Fair | 59 | 41 | |
Poor | 56 | 44 | |
Routine place to go for healthcare | 0.0001 | ||
No | 84 | 16 | |
Yes | 62 | 38 | |
Primary source for healthcare | NS | ||
Clinic or health center | 60 | 40 | |
Doctor’s office or HMO | 62 | 38 | |
Hospital emergency room | 79 | 21 | |
Hospital outpatient department | 66 | 34 | |
Some other place | 59 | 41 | |
Received healthcare in past year | < 0.0001 | ||
No | 89 | 11 | |
Yes | 60 | 40 | |
Diabetes | < 0.0001 | ||
No | 70 | 30 | |
Yes | 37 | 63 |
*Row percentages reported weighted to the non-institutionalized U.S. population
**Aspirin eligibility determined based on the 2009 USPTF recommendations for primary prevention of CVD NS = not significant (p ≥ 0.1)